A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2002
10/24/2002	US20020156030 Heterocyclic aromatic compounds and uses thereof
10/24/2002	US20020156027 Ketolide antibiotics
10/24/2002	US20020156000 Inhibiting NF-kappa B-dependent target gene expression in a cell.
10/24/2002	US20020155992 Paclitaxel, epipodophyllotoxin, decetaxel, topotecan, and podophyllotoxin covalently conjugated to a polypeptide drug carrier having 50-90% by weight glutamic acid; inproved solubility
10/24/2002	US20020155534 SBHWSB2: a new member of the WD40 SOCS box family
10/24/2002	US20020155528 Regulation of human CysLT2-like GPCR protein
10/24/2002	US20020155115 Cancer therapy
10/24/2002	US20020153508 Cubic liquid crystalline compositions and methods for their preparation
10/24/2002	DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002	CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002	CA2444761A1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444548A1 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444247A1 Inhibitors of integrin .alpha.v.beta.6
10/24/2002	CA2444164A1 Pufa polyketide synthase systems and uses thereof
10/24/2002	CA2443805A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	CA2443777A1 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	CA2443732A1 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002	CA2443709A1 Novel cyclo azaphospha hydrocarbons
10/24/2002	CA2443699A1 Phenyl heterocyclyl ether
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002	CA2443487A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2443234A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	CA2442953A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1251177A2 Cytokine-, stress-, and oncoprotein-activited human protein kinase kinases
10/23/2002	EP1250931A1 Novel use of neuronal calcium sensor-1 (NCS-1) in therapy of CNS disorders and in the development of therapeutic agents
10/23/2002	EP1250927A2 Pharmaceutical composition for topical application comprising nifedipine
10/23/2002	EP1250925A2 Nasal spray containing ondansetron hydrochloride
10/23/2002	EP1250849A1 Morinda citrifolia (Noni) enhanced animal food product
10/23/2002	EP1250338A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors
10/23/2002	EP1250337A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/23/2002	EP1250325A1 Phenanthridine-n-oxides
10/23/2002	EP1250317A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
10/23/2002	EP1250313A1 Monohydrate of cis-lithium-cyano-4- 3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate
10/23/2002	EP1250156A1 Method for nucleic acid transfection of cells
10/23/2002	EP1250153A2 TREATMENT OF i C. DIFFICILE /i TOXIN B ASSOCIATED CONDITIONS
10/23/2002	EP1250146A2 Use of neurotoxins for treating diabetes
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	EP1250126A2 Transepithelial delivery of glp-1 derivatives
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/23/2002	EP1150702B1 Use of orosomucoid for the production of a pharmaceutical preparation for the treatment of pancreatitis
10/23/2002	EP1140191B1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
10/23/2002	EP1073642B1 The use of dihydropyrimidines as medicaments, and novel substances for the treatment of hepatitis b
10/23/2002	EP1000067B1 Thiazolobenzoheterocycles, preparation and medicines containing same
10/23/2002	EP0925303B1 Phosphinic acid amides as matrix metalloprotease inhibitors
10/23/2002	EP0923561B1 Heterocyclic metalloprotease inhibitors
10/23/2002	EP0826000B1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
10/23/2002	EP0783499B1 Benzofuran derivatives as tachykinin antagonists
10/23/2002	EP0754037A4 Methods of administering n-substituted benzamides or phenothiazines
10/23/2002	CN1376166A Peptide that lower blood glucose levels
10/23/2002	CN1376162A Novel techykinin peptides, precursor peptides thereof and genes encoding the same
10/23/2002	CN1376160A Novel macrolide antibiotics
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002	CN1376067A Conditioned cell culture medium compositions and method of use
10/23/2002	CN1376061A Treatment of hiatial hernia
10/23/2002	CN1375550A Green wine and its prepn.
10/23/2002	CN1375549A Stomach invigorating wine
10/23/2002	CN1375333A Biopreparation for treating hepatosis prepared in micro alternate bioelectric field and its prepn.
10/23/2002	CN1375325A Composite medicine for treating hepatitis B
10/23/2002	CN1375314A Fermented soybean extracted liquid and composite medicine containing the said liquid
10/23/2002	CN1375307A Externally dressing medicine for treating cholecystitis
10/23/2002	CN1375289A Ampelosis general flavone composition with liver protecting function
10/23/2002	CN1093133C 10,13,15-trioxyheterotricyclo [9,2,1,1,9,6]-pentadecanone derivatives, its preparing method and medicine containing it
10/23/2002	CN1092984C Toad skin mixture for treating hepatitis B
10/23/2002	CN1092980C Medicine for curing tooth-ache
10/23/2002	CN1092974C Chinese medicinal food
10/23/2002	CN1092970C Compound Chinese medicine for treating hepatocholepathy
10/23/2002	CN1092967C Powdered medicine for treating simple baby diarrhea
10/23/2002	CN1092965C Gause julid table for gastrosis and its preparing process
10/22/2002	US6469174 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
10/22/2002	US6469062 Use of 15-keto-prostaglandins in promoting bile secretion
10/22/2002	US6469058 For the treatment of nonsmall cell lung cancer
10/22/2002	US6469056 Pharmaceutically active compounds, their preparation and use as ECE-inhibitors
10/22/2002	US6469054 Aryl sulphonamides and analogues
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469036 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/22/2002	US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002	US6469025 For the prophylaxis or treatment of a disease or disorder in a mammal in which the extravasation of leukocytes plays a role; inhibiting the binding of alpha 4 integrins to their ligands
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469018 Compounds
10/22/2002	US6469007 P-substituted-n-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-n-pyridin-2-yl-benzamide,
10/22/2002	US6469001 IL-5 inhibiting 6-azauracil derivatives
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/22/2002	US6468997 Desmethylolanzapine compositions and methods
10/22/2002	US6468989 Gel compositions containing metronidazole
10/22/2002	US6468964 Administering to human or animal active agent capable of preventing or controlling acid and endotoxin accumulation in gastrointestinal tract, selected from antibiotics, enzymes, clays, probiotics, compounds which slow rate of passage
10/22/2002	US6468960 Therapeutic compositions and methods for enhancing angiogenesis
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468737 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
10/22/2002	US6468556 Administering conjugated linoleic acid, cla
10/22/2002	US6468542 Germination activated Ganoderma lucidum spores and method for producing the same
10/22/2002	US6468526 For therapy of vaginal and gastrointestinal infections

1 ... 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 ... 1258